Targeting the Extracellular Matrix to Increase Tumor Retention & Expand RLT Across Cancer Types

• Targeting abundant ECM components beyond tumor-cell receptors to reduce dependence on variable or low receptor expression
• Exploiting tumor-specific ECM accumulation & accessibility to deliver and retain greater radioactive retention within the tumor
• Identifying conserved ECM targets across tumor types to unlock RLT opportunities across primary & metastatic disease

Novel Target

Speakers:

Monica Gostissa

Chief Scientific Officer

Matrisome Bio